Nojima, M.; Kimura, T.; Aoki, Y.; Fujimoto, H.; Hayashi, K.; Ohtake, J.; Kimura-Asami, M.; Suzuki, K.; Urayama, K.; Matsuura, M.;
et al. A Metabolomics-Based Approach for Diagnosing NAFLD and Identifying Its Pre-Condition Along the Potential Disease Spectrum. Livers 2025, 5, 12.
https://doi.org/10.3390/livers5010012
AMA Style
Nojima M, Kimura T, Aoki Y, Fujimoto H, Hayashi K, Ohtake J, Kimura-Asami M, Suzuki K, Urayama K, Matsuura M,
et al. A Metabolomics-Based Approach for Diagnosing NAFLD and Identifying Its Pre-Condition Along the Potential Disease Spectrum. Livers. 2025; 5(1):12.
https://doi.org/10.3390/livers5010012
Chicago/Turabian Style
Nojima, Masanori, Takeshi Kimura, Yutaka Aoki, Hirotaka Fujimoto, Kuniyoshi Hayashi, Junya Ohtake, Mariko Kimura-Asami, Kazuhiko Suzuki, Kevin Urayama, Masaaki Matsuura,
and et al. 2025. "A Metabolomics-Based Approach for Diagnosing NAFLD and Identifying Its Pre-Condition Along the Potential Disease Spectrum" Livers 5, no. 1: 12.
https://doi.org/10.3390/livers5010012
APA Style
Nojima, M., Kimura, T., Aoki, Y., Fujimoto, H., Hayashi, K., Ohtake, J., Kimura-Asami, M., Suzuki, K., Urayama, K., Matsuura, M., Sato, T.-A., & Masuda, K.
(2025). A Metabolomics-Based Approach for Diagnosing NAFLD and Identifying Its Pre-Condition Along the Potential Disease Spectrum. Livers, 5(1), 12.
https://doi.org/10.3390/livers5010012
